NCT07130721View on ClinicalTrials.gov

Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

May 1, 2026

Conditions
End Stage Renal Disease on Dialysis
Interventions
DIAGNOSTIC_TEST

C-Reactive Protein (CRP) Test

Blood samples will be collected once from all participants to measure CRP levels

DIAGNOSTIC_TEST

D-dimer Test

D-dimer levels will be assessed once to evaluate thrombotic risk.

DIAGNOSTIC_TEST

Electrocardiogram (ECG)

A standard 12-lead ECG will be performed once per participant to assess cardiovascular status

Trial Locations (1)

71515

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT07130721 - Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients | Biotech Hunter | Biotech Hunter